Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Polus

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Revue Medicale De Liege|April 11, 2002
[Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1]M Polus, G Jerusalem, B Sautois, et al.
Revue Medicale De Liege|July 19, 2003
[Primary and secondary prevention of colorectal cancer]M Polus, P Piront, G Jerusalem, et al.
Revue Medicale De Liege|May 8, 2009
[Palliative management of hepatocarcinoma with sorafenib (Nexavar). Results of the SHARP study (sorafenib hepatocarcinoma assessment randomized protocol trial)]O Detry, J Delwaide, A De Roover, et al.
Revue Medicale De Liege|May 15, 2014
[Radiotherapy in rectal cancer: when, why and how?]P Martinive, D Vandaele, E Lennerts, et al.
British Journal of Cancer|January 26, 2006
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II studyA Demols, M Peeters, M Polus, et al.
Revue Medicale De Liege|May 8, 2009
[Treatment of (unresectable) hepatocellular carcinoma at an intermediate or advanced stage]D Van Daele, J Belaiche, J Delwaide, et al.
Revue Medicale De Liege|January 8, 2016
[CRITICAL VIEWPOINT ON THE CURRENT APPROACH OF LOCALIZED PANCREATIC DUCTAL ADENOCARCINOMA]D Van Daele, P Martinive, C Loly, et al.
Acta Chirurgica Belgica|April 28, 2011
Esophageal cancer surgery in patients older than 75: long term resultsCh Honoré, A Al-Azzeh, N Gilson, et al.
Revue Medicale De Liege|May 15, 2014
[Radiotherapy for elderly patient with rectal cancer: which benefit?]P Martinive, S Allepaert, D Vandaele, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|June 15, 2017
The human immunodeficiency virus (HIV1) protease inhibitor sanquinavir activates autophagy and removes lipids deposited in lipid dropletsA Polus, M Bociaga-Jasik, U Czech, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Revue Medicale De Liege|April 11, 2002
[Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1]M Polus, G Jerusalem, B Sautois, et al.
Revue Medicale De Liege|July 19, 2003
[Primary and secondary prevention of colorectal cancer]M Polus, P Piront, G Jerusalem, et al.
Revue Medicale De Liege|May 8, 2009
[Palliative management of hepatocarcinoma with sorafenib (Nexavar). Results of the SHARP study (sorafenib hepatocarcinoma assessment randomized protocol trial)]O Detry, J Delwaide, A De Roover, et al.
Revue Medicale De Liege|May 15, 2014
[Radiotherapy in rectal cancer: when, why and how?]P Martinive, D Vandaele, E Lennerts, et al.
British Journal of Cancer|January 26, 2006
Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II studyA Demols, M Peeters, M Polus, et al.
Revue Medicale De Liege|May 8, 2009
[Treatment of (unresectable) hepatocellular carcinoma at an intermediate or advanced stage]D Van Daele, J Belaiche, J Delwaide, et al.
Revue Medicale De Liege|January 8, 2016
[CRITICAL VIEWPOINT ON THE CURRENT APPROACH OF LOCALIZED PANCREATIC DUCTAL ADENOCARCINOMA]D Van Daele, P Martinive, C Loly, et al.
Acta Chirurgica Belgica|April 28, 2011
Esophageal cancer surgery in patients older than 75: long term resultsCh Honoré, A Al-Azzeh, N Gilson, et al.
Revue Medicale De Liege|May 15, 2014
[Radiotherapy for elderly patient with rectal cancer: which benefit?]P Martinive, S Allepaert, D Vandaele, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|June 15, 2017
The human immunodeficiency virus (HIV1) protease inhibitor sanquinavir activates autophagy and removes lipids deposited in lipid dropletsA Polus, M Bociaga-Jasik, U Czech, et al.
Pageof 5